The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.
Akihisa NakamuraKoji YamamotoRei TakedaRen YamadaAkinori KuboKenichi MorikawaSayaka AndoTomoe ShimazakiTakaaki IzumiMachiko UmemuraTakashi KitagatayaTaku ShigesawaKazuharu SuzukiMegumi KimuraMasato NakaiTakuya ShoGoki SudaMitsuteru NatsuizakaKoji OgawaShunsuke OhnishiToshiro SugiyamaHiroshi TakedaNaoya SakamotoPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)
sCD14 could be a useful pathophysiological marker and diagnostic adjunct distinguishing NASH from NAFLD. The use of sCD14 may allow the screening and identification of high-risk groups for NASH development and support early therapeutic interventions.
Keyphrases